Brief: Orthocell Secures Rights To High-Value Bone Regeneration Tech
20/10/2025 02:10
Oct 20 (Reuters) - Orthocell Ltd OCC.AX: OCC SECURES RIGHTS TO HIGH-VALUE BONE REGENERATION TECH INCREASES EQUITY STAKE IN MARINE BIOMEDICAL TO 12.0%, FOR TOTAL CONSIDERATION A$1 MILLION Further company coverage: OCC.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orthocell
See all newsBrief: Orthocell Reports September Quarter Revenue Of A$3.6 Million
Australia's Orthocell rises as flagship product records first Thailand sales
Brief: Orthocell Says QTRLY A$3.2 Million Revenue Achieved
Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Brief: Orthocell's First Surgical Use Of Remplir In US Department Of Defense